447 related articles for article (PubMed ID: 30770219)
1. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
[TBL] [Abstract][Full Text] [Related]
2. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
3. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
[TBL] [Abstract][Full Text] [Related]
4. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
[TBL] [Abstract][Full Text] [Related]
5. Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.
Wang D; Dai C; Li Y; Liu Y
Kidney Int; 2011 Dec; 80(11):1159-1169. PubMed ID: 21832980
[TBL] [Abstract][Full Text] [Related]
6. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis.
Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J
Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
8. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
Senouthai S; Wang J; Fu D; You Y
Inflammation; 2019 Aug; 42(4):1287-1300. PubMed ID: 30919150
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.
Jiang L; Xu L; Song Y; Li J; Mao J; Zhao AZ; He W; Yang J; Dai C
J Biol Chem; 2013 Aug; 288(32):23368-79. PubMed ID: 23803607
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
Jing Z; Wei-jie Y; Yi-Feng ZG
Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
Zhou L; Liu Y
Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
[TBL] [Abstract][Full Text] [Related]
13. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY
Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904
[TBL] [Abstract][Full Text] [Related]
14. Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury.
Yamamoto Y; Yamamoto H
Kidney Int; 2012 Oct; 82(7):733-5. PubMed ID: 22975994
[TBL] [Abstract][Full Text] [Related]
15. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease.
Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H
Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969
[TBL] [Abstract][Full Text] [Related]
16. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products.
Zhang SS; Wu Z; Zhang Z; Xiong ZY; Chen H; Huang QB
Biochem Biophys Res Commun; 2017 Jan; 482(4):1413-1419. PubMed ID: 27965099
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
20. Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signaling.
Tang Y; Wan F; Tang X; Lin Y; Zhang H; Cao J; Yang R
Int Immunopharmacol; 2023 Sep; 122():110584. PubMed ID: 37454630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]